BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38908355)

  • 21. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumour regression is not predictive for higher risk of sentinel node involvement in thin melanomas (Breslow thickness < or = 1 mm)].
    Kramkimel N; Maubec E; Boitier F; Cavalcanti A; Beldi M; Mamelle G; Kolb F; Duvillard P; Avril MF
    Ann Dermatol Venereol; 2010 Apr; 137(4):276-80. PubMed ID: 20417360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
    Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
    Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm).
    Holmberg CJ; Mikiver R; Isaksson K; Ingvar C; Moncrieff M; Nielsen K; Ny L; Lyth J; Olofsson Bagge R
    Ann Surg Oncol; 2023 Dec; 30(13):8026-8033. PubMed ID: 37574516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database.
    Jimenez Balcells C; Hay J; Keir J; Rosendahl N; Coetzer-Botha M; Wilson T; Clark S; Baade A; Becker C; Bookallil L; Clifopoulos C; Dicker T; Denby MP; Duthie D; Elliott C; Fishburn P; Foley M; Franck M; Giam I; Gordillo P; Lilleyman A; Macauley R; Maher J; McPhee E; Reid M; Shirlaw B; Siggs G; Spark R; Stretch J; van den Heever K; van Rensburg T; Watson C; Kittler H; Rosendahl C
    Australas J Dermatol; 2021 Nov; 62(4):496-503. PubMed ID: 34423846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
    Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
    J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
    Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
    Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Puleo CA; Coventry BJ; Kashani-Sabet M; Smithers BM; Paul E; Kraybill WG; McKinnon JG; Wang HJ; Elashoff R; Faries MB;
    N Engl J Med; 2014 Feb; 370(7):599-609. PubMed ID: 24521106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.
    Hayes AJ; Maynard L; Coombes G; Newton-Bishop J; Timmons M; Cook M; Theaker J; Bliss JM; Thomas JM; ; ;
    Lancet Oncol; 2016 Feb; 17(2):184-192. PubMed ID: 26790922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.
    Gimotty PA; Shore R; Lozon NL; Whitlock J; He S; Vigneau FD; Dickie L; Elder DE; Xu X; Schwartz AG; Guerry D
    J Invest Dermatol; 2016 Nov; 136(11):2168-2172. PubMed ID: 27354265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are we seeing the effects of public awareness campaigns? A 10-year analysis of Breslow thickness at presentation of malignant melanoma in the South West of England.
    Armstrong A; Powell C; Powell R; Hallam N; Taylor J; Bird J; Sarran C; Oliver D
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):324-30. PubMed ID: 24434052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermoscopy as a Tool for Estimating Breslow Thickness in Melanoma.
    Martínez-Piva MM; Vacas AS; Rodríguez Kowalczuk MV; Gallo F; Rodrígues Vasconcelos M; Mazzuoccolo LD
    Actas Dermosifiliogr (Engl Ed); 2021 May; 112(5):434-440. PubMed ID: 33259813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry.
    Dennis LK
    Arch Dermatol; 1999 Mar; 135(3):275-80. PubMed ID: 10086448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness).
    El Sharouni MA; Rawson RV; Sigurdsson V; Witkamp AJ; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    J Am Acad Dermatol; 2022 Aug; 87(2):298-305. PubMed ID: 35121073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas.
    Lipsker DM; Hedelin G; Heid E; Grosshans EM; Cribier BJ
    Arch Dermatol; 1999 Dec; 135(12):1451-6. PubMed ID: 10606049
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.